Sofinnova Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-299,691
Closed -$569K 61
2024
Q2
$569K Sell
299,691
-7,038
-2% -$13.4K 0.03% 67
2024
Q1
$871K Buy
+306,729
New +$871K 0.05% 56
2022
Q3
Sell
-187,381
Closed -$3.61M 52
2022
Q2
$3.61M Buy
187,381
+87,381
+87% +$1.68M 0.3% 44
2022
Q1
$1.29M Buy
+100,000
New +$1.29M 0.1% 47